Position in NVO
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$11,884,901
-$2,711,280 QoQ
Shares Held
247,912
-37.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#141
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$1,318,350
CallShares
27,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. NVO ranks #2 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
|
960 | $347,635 |
All Filings in NVO
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,884,901 | 247,912 | Shares | Sole | 2026-07-22 | |
| 2026-06-30 | $1,318,350 | 27,500 | Call | Sole | 2026-07-22 | |
| 2026-03-31 | $14,596,181 | 397,175 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $790,125 | 21,500 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $76,320 | 1,500 | Call | Sole | 2026-01-12 | |
| 2025-12-31 | $20,460,527 | 402,133 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,442,740 | 26,000 | Call | Sole | 2025-11-03 | |
| 2025-09-30 | $23,718,312 | 427,434 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $27,559,616 | 399,299 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $24,656,477 | 355,076 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $27,540,335 | 320,162 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $36,364,454 | 305,404 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $42,163,254 | 295,385 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $32,265,507 | 251,289 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $22,519,202 | 217,682 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $17,853,886 | 196,326 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $11,707,267 | 72,343 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $11,258,995 | 70,749 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $9,505,198 | 70,232 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $6,931,956 | 69,577 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,733,464 | 69,402 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $8,049,126 | 72,482 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $8,188,096 | 73,108 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $6,876,332 | 71,621 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,782,894 | 69,033 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,572,559 | 67,822 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $4,597,736 | 65,823 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $4,874,680 | 70,210 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,677,891 | 71,440 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,155,967 | 69,036 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||